Clinical trialPhase 1Not yet recruiting
A Phase 1 Trial Of Safety And Initial Efficacy Of Vagal Nerve Blockade For Cancer-Induced Cachexia In Patients With Metastatic Pancreatic Adenocarcinoma
- Outcome
- Ongoing
- Phase
- Phase 1
- Status
- Not yet recruiting
- Study type
- Interventional
- Start
- 30 September 2026
- Expected end
- 30 December 2028
- Enrollment
- 10 participants
- Sites
- 1
- Primary outcomes
- Safety and Adverse Events (AEs)
- Sponsor
- Other
- Results posted
- No
- Last update
- 14 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try